Viruses such as SARS-CoV-2, influenza virus and others travel from person to person essentially by hitchhiking on aerosols. These are finely dispersed particles containing liquid suspended in the air that an infected person expels when coughing, sneezing, or simply exhaling, and can be inhal
Researchers at Michigan Medicine have developed a new biomarker-based technique to screen for a rare and fatal consequence caused by monoclonal antibodies, which are used to treat a variety of tumours.
Nearly three years into the pandemic, many of us now carry antibodies against the virus--due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment. But not all immune responses are created equal, and how we first developed our antibodies may influen
Rapid, low-cost, and accurate tests are still required for epidemiological surveillance and healthcare services to monitor and contain the spread of SARS-CoV-2. Brazilian researchers have contributed to this field's efforts by creating an electrochemical immunosensor that identifies antibodi
A variety of intricate cancer therapies known as antibody-drug conjugates (ADCs) have undergone clinical testing and been approved for use on patients. To explain the possible risks associated with these medications, researchers have conducted an extensive analysis of different scientific da
ADCs, or antibody drug conjugates, are a class of complicated cancer treatments that have undergone extensive testing in clinical studies. The study explained the potential hazards related to these drugs.
The platform, described in a new paper in the journal ACS Infectious Diseases, could help to address the ongoing antibiotic resistance crisis, say the scientists. They modified and then tested red blood cells as a carrier for one of the world's only remaining resistance-proof antibiotics: Po
A new study from scientists at La Jolla Institute for Immunology gives researchers a guide to neutralizing Lassa virus using a trio of rare antibodies isolated from survivors of Lassa virus infection.
Washington [US], September 2 (ANI): Researchers have published results that show encouraging therapeutic options for patients with blood cancer and multiple myeloma after first-line treatment with bispecific antibodies fails. Bispecific antibodies are a type of antibody that can bind to two
Geneva [Switzerland], August 20 (ANI): The World Health Organization (WHO) has published its first guideline for Ebola virus disease therapeutics, with new strong recommendations for the use of two monoclonal antibodies.
Jakarta [Indonesia], July 22 (ANI/Xinhua): Indonesia was mulling the rollout of the fourth dose of COVID-19 vaccines as the pandemic is predicted to last longer than expected and the antibodies decline after six months of inoculation, Health Ministry spokesman Mohammad Syahril said on Friday
Gothenburg [Sweden], July 22 (ANI): Shortly after infection, patients infected with SARS-CoV-2 develop protective immune responses mediated by virus-specific T cells and antibodies. However, there is concern that immunity does not last, which could result in severe COVID-19 infection upon re